New York · 2025 Regular Session · Bill
A 11524: Requires the fee schedule for appropriate current procedural terminology and proprietary laboratory analysis codes be regularly updated for all mandatory biomarker precision medical testing coverage
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 11524 is a bill introduced in the New York House on May 28, 2026. According to its official title, it concerns: Requires the fee schedule for appropriate current procedural terminology and proprietary laboratory analysis codes be regularly updated for all mandatory biomarker precision medical testing coverage. Primary sponsor: Rules Committee. Most recent recorded action (May 28, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires the fee schedule for appropriate current procedural terminology and proprietary laboratory analysis codes be established and regularly updated for all mandatory biomarker precision medical testing coverage by the department of health.
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Rules Committee | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH